ClinConnect ClinConnect Logo
Search / Trial NCT04692818

3D Ultrasound Breast Imaging

Launched by MAYO CLINIC · Dec 30, 2020

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new type of ultrasound called 3D ultrasound imaging to help doctors better diagnose breast tumors. The goal is to see if this advanced imaging method can provide clearer and more accurate pictures of breast masses, which could help in making better treatment decisions.

The trial is open to adult women aged 18 and older who have a breast lesion and are already scheduled for a biopsy, which is a procedure to examine breast tissue. However, women who have had previous breast surgery, breast implants, or are currently pregnant, breastfeeding, or undergoing cancer treatment cannot participate. If you join the study, you can expect to undergo this new imaging technique along with your regular care, and your participation will contribute to important research that could improve breast cancer diagnosis in the future.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Adult women ≥ 18 years of age.
  • solid breast lesion and ultrasound guided biopsy (either as part of their clinical care or through participation in other IRB-approved studies)
  • lesion size of 3mm or larger
  • Exclusion Criteria:
  • \< 18 years of age.
  • Lacking capacity to consent
  • Pregnant or lactating
  • Receiving cancer therapy such as chemotherapy or radiation therapy

About Mayo Clinic

Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.

Locations

Rochester, Minnesota, United States

Patients applied

0 patients applied

Trial Officials

Shigao Chen, PhD

Principal Investigator

Mayo Clinic

Christine Lee, MD, PhD

Principal Investigator

Mayo Clinic in Rochester

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials